Germinal Center Kinase (MAP4K2) Human shRNA Plasmid Kit (Locus ID 5871)
CAT#: TF320502
MAP4K2 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Product images

经常一起买 (2)
Specifications
Product Data | |
Product Name | Germinal Center Kinase (MAP4K2) Human shRNA Plasmid Kit (Locus ID 5871) |
Locus ID | 5871 |
UniProt ID | Q12851 |
Synonyms | BL44; GCK; RAB8IP |
Vector | pRFP-C-RS |
Format | Retroviral plasmids |
Kit Components | MAP4K2 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector(Gene ID = 5871). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRFP-C-RS Vector, TR30015, included for free. |
RefSeq | NM_001307990, NM_004579, NM_004579.1, NM_004579.2, NM_004579.3, NM_004579.4, BC039839, BC047865, BM458161, NM_004579.5 |
Summary | The protein encoded by this gene is a member of the serine/threonine protein kinase family. Although this kinase is found in many tissues, its expression in lymphoid follicles is restricted to the cells of germinal centre, where it may participate in B-cell differentiation. This kinase can be activated by TNF-alpha, and has been shown to specifically activate MAP kinases. This kinase is also found to interact with TNF receptor-associated factor 2 (TRAF2), which is involved in the activation of MAP3K1/MEKK1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...